Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Pragmatic Trial Investigating Sentinel Lymph Node Biopsy (SLNB) Efficacy and Safety in Patients With Clinically Node-Negative (cN0), High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck

NCT06990737 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT06990737
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06990737 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Pragmatic Trial Investigating Sentinel Lymph Node Biopsy (SLNB) Efficacy and Safety in Patients With Clinically Node-Negative (cN0), High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck
Lead sponsor
University of California, Davis
Phase
Phase 2
Overall status
Withdrawn
Start date
June 25, 2025
Completion date
June 18, 2026
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

clinically node-negative (cn0), cutaneous squamous cell carcinoma of the head and neck, high-risk cutaneous squamous cell carcinoma (cscc) of the head and neck